User profiles for M. Yan

Minhong Yan

- Verified email at beigene.com - Cited by 16159

Ming Yan

- Verified email at treeline.bio - Cited by 5226

Mengyuan Yan

- Verified email at stanford.edu - Cited by 4569

Chemical and physical properties and potential mechanisms: melatonin as a broad spectrum antioxidant and free radical scavenger

…, LC Manchester, MT Yan, M El-Sawi… - Current topics in …, 2002 - ingentaconnect.com
Melatonin was found to be a potent free radical scavenger in 1993. Since then over 800
publications have directly or indirectly confirmed this observation. Melatonin scavenges a variety …

Synthetic organic electrochemical methods since 2000: on the verge of a renaissance

M Yan, Y Kawamata, PS Baran - Chemical Reviews, 2017 - ACS Publications
Electrochemistry represents one of the most intimate ways of interacting with molecules.
This review discusses advances in synthetic organic electrochemistry since 2000. Enabling …

[HTML][HTML] Aging and aging-related diseases: from molecular mechanisms to interventions and treatments

J Guo, X Huang, L Dou, M Yan, T Shen… - Signal Transduction and …, 2022 - nature.com
Aging is a gradual and irreversible pathophysiological process. It presents with declines in
tissue and cell functions and significant increases in the risks of various aging-related …

The comprehensive antibiotic resistance database

…, PL Taylor, M Thaker, W Wang, M Yan… - Antimicrobial agents …, 2013 - Am Soc Microbiol
The field of antibiotic drug discovery and the monitoring of new antibiotic resistance elements
have yet to fully exploit the power of the genome revolution. Despite the fact that the first …

Ego4d: Around the world in 3,000 hours of egocentric video

…, A Torralba, L Torresani, M Yan… - Proceedings of the …, 2022 - openaccess.thecvf.com
We introduce Ego4D, a massive-scale egocentric video dataset and benchmark suite. It offers
3,670 hours of daily-life activity video spanning hundreds of scenarios (household, outdoor…

[HTML][HTML] Polatuzumab vedotin in previously untreated diffuse large B-cell lymphoma

…, JP Gau, J Hirata, Y Jiang, M Yan… - … England Journal of …, 2022 - Mass Medical Soc
Background Diffuse large B-cell lymphoma (DLBCL) is typically treated with rituximab,
cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP). However, only 60% of …

Volumetric and multi-view cnns for object classification on 3d data

…, H Su, M Nießner, A Dai, M Yan… - Proceedings of the …, 2016 - openaccess.thecvf.com
… Ours-MO-SubvolumeSup is the subvolume supervision network in Sec 4.2 and Ours-MO
For clarity, we use MOto denote that both networks are trained with an additional multi-…

Do as i can, not as i say: Grounding language in robotic affordances

…, V Vanhoucke, F Xia, T Xiao, P Xu, S Xu, M Yan… - arXiv preprint arXiv …, 2022 - arxiv.org
… Mengyuan Yan implemented infrastructure and learning tools that allowed for learning …
1.0 J’ai renversé mon coca, peux-tu m’apporter quelque chose pour m’aider `a nettoyer 0.0 …

Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8)

…, MC Chien, J Chen, M Yan… - Proceedings of the …, 1996 - National Acad Sciences
… We would like to acknowledge Gifty Asamani and Zhou Ju-Yen for excellent technical
assistance, Ai-En Thlick for assistance with the figures, and Xiao-Lu Ye and Peisen Zhang for help …

Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers

…, LI Huschtscha, HJ Thorne, KconFab, SB Fox, M Yan… - Nature medicine, 2009 - nature.com
… However, there are fourfold fewer repopulating MaSCs in mouse mammary glands deficient
in Brca1 (M.-LA-L., EL, JEV and MAB, unpublished data), further suggesting that the luminal …